Ajou University repository

Therapeutic interventions into innate immune diseases by means of Aptamersoa mark
  • Yasmeen, Farzana ;
  • Seo, Hana ;
  • Javaid, Nasir ;
  • Kim, Moon Suk ;
  • Choi, Sangdun
Citations

SCOPUS

8

Citation Export

DC Field Value Language
dc.contributor.authorYasmeen, Farzana-
dc.contributor.authorSeo, Hana-
dc.contributor.authorJavaid, Nasir-
dc.contributor.authorKim, Moon Suk-
dc.contributor.authorChoi, Sangdun-
dc.date.issued2020-10-01-
dc.identifier.issn1999-4923-
dc.identifier.urihttps://dspace.ajou.ac.kr/dev/handle/2018.oak/31598-
dc.description.abstractThe immune system plays a crucial role in the body’s defense system against various pathogens, such as bacteria, viruses, and parasites, as well as recognizes non-self-and selfmolecules. The innate immune system is composed of special receptors known as pattern recognition receptors, which play a crucial role in the identification of pathogen-associated molecular patterns from diverse microorganisms. Any disequilibrium in the activation of a particular pattern recognition receptor leads to various inflammatory, autoimmune, or immunodeficiency diseases. Aptamers are short single-stranded deoxyribonucleic acid or ribonucleic acid molecules, also termed “chemical antibodies,” which have tremendous specificity and affinity for their target molecules. Their features, such as stability, low immunogenicity, ease of manufacturing, and facile screening against a target, make them preferable as therapeutics. Immune-system–targeting aptamers have a great potential as a targeted therapeutic strategy against immune diseases. This review summarizes components of the innate immune system, aptamer production, pharmacokinetic characteristics of aptamers, and aptamers related to innate-immunesystem diseases.-
dc.description.sponsorshipThis work was supported by the National Research Foundation of Korea (NRF-2020R1F1A1071517, 2019M3A9A8065098, 2019M3D1A1078940, and 2019R1A6A1A11051471), and was also partly the result of the \Leaders in Industry-university Cooperation +\ project supported by the Ministry of Education and National Research Foundation of Korea and a grant of the Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea(grant number: HI19C0760).-
dc.language.isoeng-
dc.publisherMDPI AG-
dc.titleTherapeutic interventions into innate immune diseases by means of Aptamers-
dc.typeReview-
dc.citation.endPage30-
dc.citation.startPage1-
dc.citation.titlePharmaceutics-
dc.citation.volume12-
dc.identifier.bibliographicCitationPharmaceutics, Vol.12, pp.1-30-
dc.identifier.doi10.3390/pharmaceutics12100955-
dc.identifier.scopusid2-s2.0-85092449747-
dc.identifier.urlhttps://www.mdpi.com/1999-4923/12/10/955/pdf-
dc.subject.keywordAptamer-
dc.subject.keywordInnate immune system-
dc.subject.keywordPattern recognition receptor-
dc.subject.keywordTargeted therapy-
dc.description.isoatrue-
dc.subject.subareaPharmaceutical Science-
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Kim, Moon Suk Image
Kim, Moon Suk김문석
Department of Applied Chemistry & Biological Engineering
Read More

Total Views & Downloads

File Download

  • There are no files associated with this item.